These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8230751)

  • 21. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
    Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
    J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
    Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
    Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
    Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of the AML-XH-99-M3 protocol for treatment of acute promyelocytic leukemia in children].
    Chen J; Gu LJ; Tang JY; Xue HL; Pan C; Ye QD; Jiang H; Dong L; Zhou M; Wang YP
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):329-32. PubMed ID: 18554461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S; Ullah K; Ahmed P; Khan B
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
    de Botton S; Fawaz A; Chevret S; Dombret H; Thomas X; Sanz M; Guerci A; San Miguel J; de la Serna J; Stoppa AM; Reman O; Stamatoulas A; Fey M; Cahn JY; Sotto JJ; Bourhis JH; Parry A; Chomienne C; Degos L; Fenaux P
    J Clin Oncol; 2005 Jan; 23(1):120-6. PubMed ID: 15534358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
    Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
    Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood acute promyelocytic leukemia: a rare variant of nonlymphoid leukemia with distinctive clinical and biologic features.
    Carter M; Kalwinsky DK; Dahl GV; Santana VM; Mason CA; Schell MJ
    Leukemia; 1989 Apr; 3(4):298-302. PubMed ID: 2927178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute myeloid leukemia in the adult. Results of the National Antineoplastic Drug Protocol at the Hospital del Salvador, 1990-1998].
    Puga BL; Cabrera ME; Undurraga MS; Etcheverry R; Vacarezza R; Ducach G; Toledo H
    Rev Med Chil; 2000 Nov; 128(11):1191-8. PubMed ID: 11347505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved outcome for Chinese children with acute promyelocytic leukemia: a comparison of two protocols.
    Luo XQ; Ke ZY; Huang LB; Guan XQ; Zhang YC; Zhang XL
    Pediatr Blood Cancer; 2009 Sep; 53(3):325-8. PubMed ID: 19422024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute promyelocytic leukemia.
    Kingsley EC; Durie BG; Garewal HS
    West J Med; 1987 Mar; 146(3):322-7. PubMed ID: 3472414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective analysis of 65 Chinese children with acute promyelocytic leukemia: a single center experience.
    Zhang L; Zhao H; Zhu X; Chen Y; Zou Y; Chen X
    Pediatr Blood Cancer; 2008 Aug; 51(2):210-5. PubMed ID: 18428427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study.
    Jastaniah W; Alsultan A; Al Daama S; Ballourah W; Bayoumy M; Al-Anzi F; Al Shareef O; Abrar MB; Al Sudairy R; Al Ghemlas I
    Hematology; 2018 Jul; 23(6):316-323. PubMed ID: 29212418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in children with acute lymphoblastic leukemia. Part I: Univariate analysis. Children's Cancer and Leukemia Study Group.
    Hiyoshi Y; Fujimoto T; Kuriya N; Otani Y; Mibu K; Yanai M; Sasaki K; Shingaki Y; Yokoyama T; Kadoya S
    Jpn J Clin Oncol; 1985 Mar; 15(1):3-12. PubMed ID: 3856696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute promyelocytic leukemia, centre, experience, Turkey.
    Yildirim R; Gundogdu M; Ozbıcer A; Kiki I; Erdem F; Dogan H
    Transfus Apher Sci; 2013 Feb; 48(1):45-9. PubMed ID: 22892289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trial of daunomycin in acute promyelocytic leukemia of childhood: a Southwest Oncology Group Study.
    van Eys J; Steuber P; Haggard ME; Sabio H; Duncan M
    Am J Pediatr Hematol Oncol; 1981; 3(3):301-3. PubMed ID: 7025685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.